Unveiling the Uncommon: A Unique Case of ALPS-Like Syndrome Complicated by Plasma Cell Disorder.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
received:
26
11
2023
accepted:
14
03
2024
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
23
4
2024
Statut:
aheadofprint
Résumé
Multiple myeloma is a rare disease in pediatrics, where about 30 cases are described under 15 years old. It is even rarer when atypical multiple myeloma occurs in the context of autoimmunity. This case describes a 9-year-old female with autoimmune lymphoproliferative-like disease and combined immune deficiency that developed acute kidney failure with monoclonal peak associated with RAC2 and TNFRSF9 variants. An adapted protocol from the backbone adult multiple myeloma standard of care with the addition of an allogeneic hematopoietic stem cell transplant was used. The patient, now nearly a year posttransplant, shows 100% chimerism with no sign of relapse.
Identifiants
pubmed: 38652075
doi: 10.1097/MPH.0000000000002859
pii: 00043426-990000000-00403
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Hemminki K, Forsti A, Houlston R, et al. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. Int J Cancer. 2021;149:1980–1996.
Blade J, Kyle RA, Greipp PR. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. Arch Intern Med. 1996;156:1463–1468.
Wang X, He H, Zhang M, et al. Case report: Multiple vertebral compression fractures in 14-year-old children with multiple myeloma. Front Oncol. 2021;11:662169.
Crusoe Ede Q, da Silva AM, Agareno J, et al. Multiple myeloma: A rare case in an 8-year-old child. Clin Lymphoma Myeloma Leuk. 2015;15:e31–e33.
Sironi M, Guerini FR, Agliardi C, et al. An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases. Mol Biol Evol. 2011;28:3319–3329.
Donko A, Sharapova SO, Kabat J, et al. Clinical and functional spectrum of RAC2-related immunodeficiency. Blood. 2024.
Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860–1873.
Hewell GM, Alexanian R. Multiple myeloma in young persons. Ann Intern Med. 1976;84:441–443.
Callander NS, Baljevic M, Adekola K, et al. NCCN Guidelines(R) Insights: Multiple myeloma, Version 3.2022. J Natl Compr Canc Netw. 2022;20:8–19.
Krejcik J, Casneuf T, Nijhof IS, et al. Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood. 2016;128:384–394.
Mikhael J, Ismaila N, Cheung MC, et al. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. J Clin Oncol. 2019;37:1228–1263.
Davidow KA, Walter AW, Kolb EA. Bone marrow transplant and pediatric multiple myeloma. Pediatr Blood Cancer. 2019;66:e27528.